Leukemia & Lymphoma, Volume 63, Issue 9 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 63, Issue 9 (2022)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Volume 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Real world CAR T cell data in diffuse large B-cell lymphoma: hitting a moving target
Samuel Yamshon & Hsu Jing-Mei
Pages: 2019-2020
Published online: 12 Jul 2022
CitationforReal world CAR T cell data in diffuse large B-cell lymphoma: hitting a moving target | Full Text | References | PDF (241.7 KB) | EPUB
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Response-adapted approach in newly diagnosed myeloma: when less is at least equal
Elisabet E. Manasanch & Morie A. Gertz
Pages: 2021-2022
Published online: 12 Sep 2022
CitationforResponse-adapted approach in newly diagnosed myeloma: when less is at least equal | Full Text | References | PDF (240.6 KB) | EPUB
  • 96 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
The role of BTK inhibitors on the tumor microenvironment in CLL
Joel McCay & John G. Gribben
Pages: 2023-2032
Published online: 23 Apr 2022
AbstractforThe role of BTK inhibitors on the tumor microenvironment in CLL | Full Text | References | PDF (1.3 MB) | EPUB
  • 525 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Smoldering multiple myeloma: Reviewing the rationale for intervention
Morie Gertz
Pages: 2033-2040
Published online: 09 May 2022
AbstractforSmoldering multiple myeloma: Reviewing the rationale for intervention | Full Text | References | PDF (724.9 KB) | EPUB
  • 261 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphoma
Max J. Gordon, Anna Sureda & Jason R. Westin
Pages: 2041-2051
Published online: 12 May 2022
AbstractforNovel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphoma | Full Text | References | PDF (1.2 MB) | EPUB
  • 402 Views
  • 0 CrossRef citations
  • 0Altmetric

Articles

Article
Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States
Richard T. Maziarz, Hongbo Yang, Qing Liu, Travis Wang, Jing Zhao, Stephen Lim, Soyon Lee, Anand Dalal & Vamsi Bollu
Pages: 2052-2062
Published online: 14 Apr 2022
AbstractforReal-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3053 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL
Deborah A. Katz, Joan D. Morris, Michael P. Chu, Kevin A. David, Catherine Thieblemont, Nicholas J. Morley, Sharif S. Khan, Andreas Viardot, Alejandro Martín García-Sancho, Guillermo Rodríguez-García, Mariana Bastos-Oreiro, Seung Tae Lee, William Kormany, Yuqi Chen, Hansen L. Wong, Abraham A. Anderson, Yuliya Katlinskaya, Ariel A. Avilion, Tian Dai & Eva González-Barca
Pages: 2063-2073
Published online: 03 May 2022
AbstractforOpen-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 3332 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study
Maja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, Henriette Engberg, Pernille Hammershøj Jensen, Helene Bjørg Kristensen, Joachim Baech, Michael Roost Clausen, Anne Ortved Gang, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen & Thomas Stauffer Larsen
Pages: 2074-2083
Published online: 18 Apr 2022
AbstractforCardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 295 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Average lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Japan, 1990–2015
Truong-Minh Pham, Pham Nguyen Quy, Khalid Amin, Emily Walker, Lorraine Shack, Winson Y. Cheung, Tatsuhiko Kubo, Yoshihisa Fujino, Takehiro Higashi, Junichi Tsukada & Shinya Matsuda
Pages: 2084-2093
Published online: 23 Apr 2022
AbstractforAverage lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Japan, 1990–2015 | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 146 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center
Dylan J. Martini, Subir Goyal, Jeffrey M. Switchenko, Mary Jo Lechowicz & Pamela B. Allen
Pages: 2094-2101
Published online: 28 Apr 2022
AbstractforAfrican American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 808 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
Eyal Lebel, Neta Goldschmidt, Tali Siegal, Alexander Lossos, Shai Rosenberg, Chen Makranz, Eduard Linetski, Moshe E. Gatt, Alexander Gural, Revital Saban, David Lavie, Vladimir Vainstein, Eran Zimran, Batia Avni, Sigal Grisaro, Adir Shaulov & Boaz Nachmias
Pages: 2102-2108
Published online: 02 May 2022
AbstractforRituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma | Full Text | References | PDF (914.2 KB) | EPUB | Supplemental
  • 252 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis
Madeleine B. Hopson, Divaya Bhutani, Shawn Sarkaria, Mathew S. Maurer, Jan M. Griffin, Markus Mapara, Suzanne Lentzsch & Rajshekhar Chakraborty
Pages: 2109-2113
Published online: 23 Apr 2022
AbstractforImpact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis | Full Text | References | PDF (744.3 KB) | EPUB | Supplemental
  • 118 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Homozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas
Melissa Ferrad, Nour Ghazzaui, Hussein Issaoui, Emilie Drouineau, Christelle Oblet, Tiffany Marchiol, Jeanne Cook-Moreau & Yves Denizot
Pages: 2114-2125
Published online: 28 Apr 2022
AbstractforHomozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas | Full Text | References | PDF (2.4 MB) | EPUB
  • 774 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B. Lahoud, Heather Landau, James Nguyen, Sean Devlin, Nikoletta Lendvai, Jonathan Weltz, Tumininu Ayorinde, David J. Chung, Alexander M. Lesokhin, Tarun Kewalramani, Neha Korde, Sham Mailankody, Ola Landgren, Sergio Giralt, Raymond L. Comenzo & Hani Hassoun
Pages: 2126-2135
Published online: 01 Jun 2022
AbstractforContinuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach | Full Text | References | PDF (1.5 MB) | EPUB
  • 251 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia
Qiaoqiao Li, Chunyan Liang, Xintong Xu, Congli Zhang, Weijie Cao, Meng Wang, Zhongxing Jiang, Haizhou Xing & Jifeng Yu
Pages: 2136-2148
Published online: 23 Apr 2022
AbstractforCLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia | Full Text | References | PDF (3.3 MB) | EPUB | Supplemental
  • 426 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
JMJD1C-regulated lipid synthesis contributes to the maintenance of MLL-rearranged acute myeloid leukemia
Daoxin Qi, Jialing Wang, Yao Zhao, Yong Yang, Yishu Wang, Haihua Wang, Lin Wang, Zhanju Wang, Xin Xu & Zhenbo Hu
Pages: 2149-2160
Published online: 25 Apr 2022
AbstractforJMJD1C-regulated lipid synthesis contributes to the maintenance of MLL-rearranged acute myeloid leukemia | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 389 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia
Nicholas J. Short, Gautam Borthakur, Naveen Pemmaraju, Courtney D. Dinardo, Tapan M. Kadia, Elias Jabbour, Marina Konopleva, Walid Macaron, Jing Ning, Junsheng Ma, Sherry Pierce, Yesid Alvarado, Koji Sasaki, Koichi Takahashi, Zeev Estrov, Lucia Masarova, Ghayas C. Issa, Guillermo Montalban-Bravo, Michael Andreeff, Jan A. Burger, Darla Miller, Lynette Alexander, Aung Naing, Guillermo Garcia-Manero, Farhad Ravandi & Naval Daver
Pages: 2161-2170
Published online: 20 Apr 2022
AbstractforA multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 606 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study
Mara Memoli, Alexis Genthon, Fabrizia Favale, Simona Lapusan, Natacha Johnson, Rosa Adaeva, Caroline Deswarte, Giorgia Battipaglia, Florent Malard, Rémy Duléry, Eolia Brissot, Anne Banet, Zoé Van de Wyngaert, Mohamad Mohty, François Delhommeau, Ollivier Legrand & Pierre Hirsch
Pages: 2171-2179
Published online: 22 Apr 2022
AbstractforPrognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 190 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
Thomas Prebet, Aaron D. Goldberg, Joseph G. Jurcic, Samer Khaled, Monique Dail, Yuning Feng, Cherie Green, Chunze Li, Connie Ma, Bruno C. Medeiros, Mark Yan & Michael R. Grunwald
Pages: 2180-2188
Published online: 01 May 2022
AbstractforA phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia | Full Text | References | PDF (882.5 KB) | EPUB | Supplemental
  • 310 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Performance of the frailty index in predicting complete remission, intensive care unit admission, and overall mortality in older and younger patients with acute myeloid leukemia receiving intensive chemotherapy
Dmitriy Petrov, Narhari Timilshina, Efthymios Papadopoulos & Shabbir M.H Alibhai
Pages: 2189-2196
Published online: 22 Apr 2022
AbstractforPerformance of the frailty index in predicting complete remission, intensive care unit admission, and overall mortality in older and younger patients with acute myeloid leukemia receiving intensive chemotherapy | Full Text | References | PDF (670.2 KB) | EPUB | Supplemental
  • 173 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
Masaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Yosuke Okada, Machiko Kusuda, Kazuaki Kameda, Yu Akahoshi, Shun-ichi Kimura, Shinichi Kako & Yoshinobu Kanda
Pages: 2197-2205
Published online: 07 Apr 2022
AbstractforRisk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 194 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia
Eugenia Miranti, Dora Y. Ho, Kyle Enriquez, Aruna K. Subramanian, Bruno C. Medeiros & David J. Epstein
Pages: 2206-2212
Published online: 12 Apr 2022
AbstractforEpidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia | Full Text | References | PDF (748.3 KB) | EPUB | Supplemental
  • 250 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience
Elżbieta Szczepanek, Ositadima Chukwu, Magdalena Kamińska, Hubert Wysogląd, Agnieszka Cenda, Magdalena Zawada, Małgorzata Jakóbczyk, Joanna Wącław & Tomasz Sacha
Pages: 2213-2223
Published online: 02 May 2022
AbstractforLong-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 280 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Effects of imatinib on glycemic and lipid profiles: a retrospective cohort study
Noa Markovits, Daniel Kurnik, Carmel Friedrich, Itai Gueta, Hillel Halkin, Sara David, Yossi Lomnicky, Yael Topol, Amir Tirosh & Ronen Loebstein
Pages: 2224-2232
Published online: 27 Apr 2022
AbstractforEffects of imatinib on glycemic and lipid profiles: a retrospective cohort study | Full Text | References | PDF (972.3 KB) | EPUB
  • 231 Views
  • 2 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
Alyce M. Kuo, Hani Hassoun, Urvi Shah, Allison Gordon, Travis J. Hollmann, Heather J. Landau, Cecilia Lezcano, Sham Mailankody, Carlyn C. Tan, Alexander M. Lesokhin & Alina Markova
Pages: 2233-2237
Published online: 09 May 2022
First Page PreviewforDupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma | Full Text | References | PDF (1.1 MB) | EPUB
  • 615 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Response to trametinib of two pediatric myeloid malignancies cases harboring RAS mutation and monosomy 7
Juanjuan Li, Junhui Li, Tao Hu, Xiaodai Cui, Zeliang Song, Xiaodong Shi & Rong Liu
Pages: 2238-2242
Published online: 12 Jun 2022
First Page PreviewforResponse to trametinib of two pediatric myeloid malignancies cases harboring RAS mutation and monosomy 7 | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 110 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Apparent coexistence of ETV6::RUNX1 and KMT2A::MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL
Marie-France Gagnon, James B. Smadbeck, Neeraj Sharma, Patrick R. Blackburn, Jonna Demasi Benevides, Yassmine M. N. Akkari, Jennifer J. Jaroscak, Iya Znoyko, Daynna J. Wolff, Cynthia A. Schandl, Reid Meyer, Patricia T. Greipp, Xinjie Xu, Nicole L. Hoppman, Rhett P. Ketterling, Jess F. Peterson & Linda B. Baughn
Pages: 2243-2246
Published online: 04 May 2022
First Page PreviewforApparent coexistence of ETV6::RUNX1 and KMT2A::MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1477 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter
Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and KIT mutation relapse post allo-HSCT
Song Xue, Wenqiu Huang, Fuhong Liu, Yongping Zhang, Qi Hao, Bin Cui, Suning Chen & Jingbo Wang
Pages: 2247-2250
Published online: 19 Apr 2022
First Page PreviewforRapid response to avapritinib of acute myeloid leukemia with t(8;21) and KIT mutation relapse post allo-HSCT | Full Text | References | PDF (941.8 KB) | EPUB
  • 276 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
CD22 expression in acute myeloid leukemia: close correlation with interleukin-2 receptor α-chain (CD25) expression and poor prognosis
Kazunori Nakase, Isao Tanaka, Isao Tawara & Hiroshi Shiku
Pages: 2251-2253
Published online: 20 Apr 2022
First Page PreviewforCD22 expression in acute myeloid leukemia: close correlation with interleukin-2 receptor α-chain (CD25) expression and poor prognosis | Full Text | References | PDF (407.9 KB) | EPUB | Supplemental
  • 202 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Treatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation
Julian Lindsay, Matthew Greenwood, Jad Othman, Sharon C.-A. Chen, David C. M. Kong, Steven A. Pergam, Catherine Liu & Monica A. Slavin
Pages: 2254-2256
Published online: 15 Apr 2022
First Page PreviewforTreatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation | Full Text | References | PDF (726.9 KB) | EPUB
  • 169 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia
Lihong Zong, Jundan Xie, Jinyu Kong, Xiebing Bao, Xiaoxia Wu, Yan Pu, Jian Zhang & Huiying Qiu
Pages: 2257-2259
Published online: 23 Jun 2022
First Page PreviewforLineage switch from acute myeloid leukemia to acute lymphoblastic leukemia | Full Text | References | PDF (519.5 KB) | EPUB
  • 143 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin
T. Strüßmann, R. Wäsch, F. Scherer, J. A. Mutter, D. Pfeifer, I. Bartsch, S. Giesler, G. Graziani, J. Duyster, J. Finke & R. Marks
Pages: 2260-2262
Published online: 20 May 2022
First Page PreviewforA patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin | Full Text | References | PDF (491.7 KB) | EPUB
  • 187 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles